triphenyltetrazolium has been researched along with rifampin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, M; Kilic, E; Kilic, U; Yulug, B | 1 |
| Behdani, M; Farnia, P; Ghanaat, J; Ghazvini, K; Mohammadzadeh, A; Rashed, T | 1 |
2 other study(ies) available for triphenyltetrazolium and rifampin
| Article | Year |
|---|---|
Rifampicin attenuates brain damage in focal ischemia.
Topics: Animals; Brain Infarction; Brain Ischemia; Cell Count; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Reperfusion; Reperfusion Injury; Rifampin; Tetrazolium Salts | 2004 |
Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tetrazolium Salts; Tuberculosis | 2006 |